The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.
暂无分享,去创建一个
[1] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[2] B. Pitt. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). , 1996, The American journal of cardiology.
[3] E. Aliot,et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.
[4] U. Elkayam,et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. , 1995, Journal of the American College of Cardiology.
[5] H. Krum,et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. , 1995, Circulation.
[6] A. Gentile,et al. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). , 1995, American heart journal.
[7] R. Falk,et al. Is aspirin safe for patients with heart failure? , 1995, British heart journal.
[8] P C Deedwania,et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.
[9] G. Schuler,et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. , 1995, Journal of the American College of Cardiology.
[10] W. Remme,et al. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. , 1994, Journal of cardiovascular pharmacology.
[11] C. Brunelli,et al. Efficacy of L-propionylcarnitine treatment in patients with left ventricular dysfunction. , 1994, European heart journal.
[12] H. Doval,et al. Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.
[13] O. Alfieri,et al. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. , 1994, Journal of the American College of Cardiology.
[14] K. Channer,et al. Combination diuretic treatment in severe heart failure: a randomised controlled trial. , 1994, British heart journal.
[15] K. Swedberg,et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.
[16] M. Gheorghiade,et al. WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .
[17] J. Brouwer,et al. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). , 1993, Journal of the American College of Cardiology.
[18] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[19] B. Uretsky,et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. , 1993, Journal of the American College of Cardiology.
[20] M. Borggrefe,et al. Do patients with an implantable defibrillator live longer? , 1993, Journal of the American College of Cardiology.
[21] A. Donker,et al. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. , 1993, The American journal of cardiology.
[22] D. Cooper,et al. Returning to work after heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[23] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[24] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[25] F. Rengo,et al. Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure. , 1992, Arzneimittel-Forschung.
[26] G. Riegger,et al. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure. , 1992, The American journal of cardiology.
[27] K. Swedberg,et al. Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). , 1992, The American journal of cardiology.
[28] H. Crijns,et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. , 1992, JAMA.
[29] S. Adamopoulos,et al. Controlled Trial of Physical Training in Chronic Heart Failure: Exercise Performance, Hemodynamics, Ventilation, and Autonomic Function , 1992, Circulation.
[30] R. Campbell,et al. Guidelines for the use of implantable cardioverter defribrillators , 1992 .
[31] D. DeMets,et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.
[32] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[33] F. Tristani,et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.
[34] J. Anderson,et al. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States. , 1991, American heart journal.
[35] H. Herrmann,et al. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. , 1990, Circulation.
[36] E. Fleck,et al. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases. , 1990, The American journal of cardiology.
[37] S. Adamopoulos,et al. Effects of physical training in chronic heart failure , 1990, The Lancet.
[38] W. Stevenson,et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.
[39] S. Rahimtoola,et al. The hibernating myocardium. , 1989, American heart journal.
[40] J Brandt,et al. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. , 1988, American heart journal.
[41] S. Gottlieb,et al. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.
[42] C. Cipolla,et al. Hemofiltration as short-term treatment for refractory congestive heart failure. , 1987, The American journal of medicine.
[43] G. Flaker,et al. Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. , 1987, American heart journal.
[44] B. Pitt,et al. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. , 1986, American heart journal.
[45] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .
[46] G. Flaker,et al. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. , 1986, Journal of the American College of Cardiology.
[47] R. Gunnar,et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. , 1985, Circulation.
[48] J. Anderson,et al. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.
[49] R. Luchi,et al. Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure , 1984, Journal of the American Geriatrics Society.
[50] K. Swedberg,et al. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. , 1980, British heart journal.
[51] C. Edmonds,et al. Total-body potassium in hypertension patients during prolonged diuretic therapy. , 1972, Lancet.